Medirin Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ambala Cantt, Haryana, India, established in 2019.
2019 Ambala Cantt, Haryana, India Active
Last Updated:
Access Report
About Medirin Pharmaceuticals Private Limited

Medirin Pharmaceuticals Private Limited, a active private limited company, was established on 27 May 2019 in Ambala Cantt, Haryana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24304HR2019PTC080556. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Its leadership includes Sanjeev Aggarwal (Director), Raman Aggarwal (Director), Pankaj Aggarwal (Director). Past directors included Jatinder Pal Singh, Parvinder Pal Singh Dhillon. It holds ₹2.78 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 6275/11, Nicholson Road, Ambala Cantt, Haryana, 133001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304HR2019PTC080556

  • Registration Number

    080556

  • Incorporation Date

    27 May 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 6 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 2.78 Cr
  • Revenue Growth **** -75.88%
  • Profit Growth **** -81.52%
  • Ebitda **** -126.46%
  • Net Worth -8.87%
  • Total Assets **** 18.04%
Company report

Medirin Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medirin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Medirin Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sanjeev Aggarwal Director 20 Feb 2020 Current
Raman Aggarwal Director 27 May 2019 Current
Pankaj Aggarwal Director 02 Feb 2024 Current
Tarun Dua Director 02 Feb 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 28 Mar 2023 Past
Pramod Abcsdd Director 28 Mar 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medirin Pharmaceuticals.

Medirin Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 75.88% decrease. The company also saw a substantial fall in profitability, with a 81.52% decrease in profit. The company's net worth dipped by a decrease of 8.87%.

Medirin Pharmaceuticals revenue growth over time
Medirin Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -75.88%
*******
*******
*******
*******
Revenue from Operations
*******
 -79.37%
*******
*******
*******
*******
Total Assets
*******
 18.04%
*******
*******
*******
*******
Profit or Loss
*******
 -81.52%
*******
*******
*******
*******
Net Worth
*******
 -8.87%
*******
*******
*******
*******
EBITDA
*******
 -126.46%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medirin Pharmaceuticals?

Unlock access to Medirin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹27,835,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 2.78 Cr
Latest Charge Details
Date Lender Amount Status
29 Jun 2021 Hdfc Bank Limited ₹2.78 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Medirin Pharmaceuticals?

Unlock and access historical data on people associated with Medirin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medirin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medirin Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medirin Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Medirin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Medirin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.

  • Director Appointment

    Progress on Pankaj Aggarwal was appointed as a Director was appointed as a Director on 02 Feb 2024 & has been associated with this company since 2 years 16 days . was documented.

  • Director Appointment

    The activity Tarun Dua was appointed as a Director was appointed as a Director on 02 Feb 2024 & has been associated with this company since 2 years 16 days . was completed.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 27.84 M registered on 29 Jun 2021 with Charge ID 100478893 was modified on 04 Oct 2023. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 27.84 M with Charge ID 100478893 was registered on 29 Jun 2021. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medirin Pharmaceuticals Private Limited?

The CIN of Medirin Pharmaceuticals Private Limited is U24304HR2019PTC080556.

Where is Medirin Pharmaceuticals Private Limited headquartered?

Medirin Pharmaceuticals Private Limited is headquartered at 6275/11, Nicholson Road, Ambala Cantt, Haryana, 133001.

When was Medirin Pharmaceuticals Private Limited incorporated?

Medirin Pharmaceuticals Private Limited was incorporated on 27 May 2019.

Who are the current directors of Medirin Pharmaceuticals Private Limited?

The current directors of Medirin Pharmaceuticals Private Limited are

What is the primary industry of Medirin Pharmaceuticals Private Limited?

The primary industry of Medirin Pharmaceuticals Private Limited is Trade.

Is Medirin Pharmaceuticals Private Limited a listed company?

Medirin Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Medirin Pharmaceuticals Private Limited?

The authorized capital of Medirin Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available